Open AccessRET genetic screening in patients with medullary thyroid cancer: The Moroccan experience
Author(s) -
Ainahi Abdelhakim,
Barlier Anne,
Kebbou Mohamed,
Benabdeljalil Nadia,
Mohammed Timinouni,
Taoufiq Fechtali,
Catherine Roche,
Saïd El Antri
Publication year - 2009
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.57126
Subject(s) - multiple endocrine neoplasia type 2 , germline mutation , germline , genetics , medullary thyroid cancer , medicine , thyroid carcinoma , mutation , proband , exon , medullary carcinoma , genetic testing , oncology , cancer research , biology , thyroid , gene
Germline RET gene mutations are well known to be the genetic causes of multiple endocrine neoplasia type 2 (MEN2) and may be identified by genetic screening.